TD Cowen Initiates Coverage On Kalaris Therapeutics with Buy Rating
Kalaris Therapeutics Inc KLRS
$4.72
▲ +3.74%
(+$0.17)
Open
$4.57
Prev Close
$4.55
Day Range
$4.55 – $4.80
52W Range
$2.14 – $11.88
Market Cap
$103.03M
Beta
0.21
EPS (TTM)
$-2.21
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2020-07-30 |
| Shares Out. | 23,790,000 |
| Website | kalaristx.com/ ↗ |
| Phone | 16502492727 |
Kalaris Therapeutics Inc is a publicly traded company under the ticker symbol KLRS on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
14 analysts (2026-06-01)